Mycobacterium leprae: Genes, pseudogenes and genetic diversity

Future Microbiology

Volumn 6, Issue 1, 2011, Pages 57-71

  Singh, Pushpendra ^a   Cole, Stewart T ^a  

^a EPFL   (Switzerland)

Author keywords

drug resistance; leprosy; molecular epidemiology; Mycobacterium leprae; phylogeography; pseudogene

Indexed keywords

CLOFAZIMINE; DAPSONE; MINOCYCLINE; OFLOXACIN; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BIOCHEMISTRY; DISEASE TRANSMISSION; DRUG BINDING; DRUG MECHANISM; GENE MAPPING; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOME; HUMAN; LEPROSY; MOLECULAR TYPING; MYCOBACTERIUM LEPRAE; NONHUMAN; PAUCIBACILLARY LEPROSY; PHYLOGEOGRAPHY; PRIORITY JOURNAL; PSEUDOGENE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

BASE COMPOSITION; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; GENETIC VARIATION; GENOME, BACTERIAL; HUMANS; LEPROSY; MYCOBACTERIUM LEPRAE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSEUDOGENES;

MYCOBACTERIUM LEPRAE;

EID: 78650491780     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.153     Document Type: Review

References (116)

1. Britton WJ, Lockwood DN: Leprosy. Lancet 363(9416), 1209-1219 (2004).
2. Ridley DS, Jopling WH: Classification of leprosy according to immunity. A five-group system. Int. J. Lepr. Other Mycobact. Dis. 34(3), 255-273 (1966).
3. World Health Organization. Global leprosy situation, 2010. Wkly Epidemiol. Rec. 85(35), 337-348 (2009).
4. Lowe J: Comments on the history of leprosy. Indian Medical Gazette 77, 680-685 (1942)
5. reprinted in Lepr. Rev. 1918, 1954-1964 (1947).
6. Dharmendra. History of spread and decline of leprosy. Ministry of Health, India (2nd Edition) (1967).
7. Browne SG: The history of leprosy. Leprosy Hastings RC (Ed.). Churchill Livingstone, UK 1-14 (1985).
8. Hulse EV: Leprosy and ancient Egypt. Lancet 2(7785), 1024-1025 (1972).
9. Robbins G, Tripathy VM, Misra VN et al.: Ancient skeletal evidence for leprosy in India (2000 B.C.). PLoS ONE 4(5), e5669 (2009).
10. Kirchheimer WF, Sanchez RM: Leprosy-susceptibility testing of armadillos. 2. Late cell and bacterial responses at inoculation site of living leprosy bacilli in 'resistant' armadillos. Microbios 8(31), 241-246 (1973).
11. Cole ST, Eiglmeier K, Parkhill J et al.: Massive gene decay in the leprosy bacillus. Nature 409(6823), 1007-1011 (2001).
12. Gomez-Valero L, Rocha EP, Latorre A, Silva FJ: Reconstructing the ancestor of Mycobacterium leprae: the dynamics of gene loss and genome reduction. Genome Res. 17(8), 1178-1185 (2007).
13. Curtiss R 3rd, Blower S, Cooper K, Russell D, Silverstein S, Young L: Leprosy research in the post-genome era. Lepr. Rev. 72(1), 8-22 (2001).
14. Eiglmeier K, Parkhill J, Honore N et al.: The decaying genome of Mycobacterium leprae. Lepr. Rev. 72(4), 387-398 (2001).
15. Vissa VD, Brennan PJ: The genome of Mycobacterium leprae: a minimal mycobacterial gene set. Genome Biol. 2(8), REVIEWS1023 (2001).
16. Wheeler PR: The microbial physiologist's guide to the leprosy genome. Lepr. Rev. 72(4), 399-407 (2001).
17. Araoz R, Honore N, Banu S et al.: Towards an immunodiagnostic test for leprosy. Microbes Infect. 8(8), 2270-2276 (2006).
18. Geluk A, Spencer JS, Bobosha K et al.: From genome-based in silico predictions to ex vivo verification of leprosy diagnosis. Clin. Vaccine Immunol. 16(3), 352-359 (2009).
19. Parkhill J, Wren BW, Thomson NR et al.: Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413(6855), 523-527 (2001).
20. Parkhill J, Sebaihia M, Preston A et al.: Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat. Genet. 35(1), 32-40 (2003).
21. Cole ST, Supply P, Honore N: Repetitive sequences in Mycobacterium leprae and their impact on genome plasticity. Lepr. Rev. 72(4), 449-461 (2001).
22. Williams DL, Gillis TP, Portaels F: Geographically distinct isolates of Mycobacterium leprae exhibit no genotypic diversity by restriction fragment-length polymorphism analysis. Mol. Microbiol. 4(10), 1653-1659 (1990).
23. Monot M, Honore N, Garnier T et al.: Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat. Genet. 41(12), 1282-1289 (2009).
24. Stinear TP, Seemann T, Pidot S et al.: Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Res. 17(2), 192-200 (2007).
25. Liu Y, Harrison PM, Kunin V, Gerstein M: Comprehensive analysis of pseudogenes in prokaryotes: widespread gene decay and failure of putative horizontally transferred genes. Genome Biol. 5(9), R64 (2004).
26. Babu MM: Did the loss of sigma factors initiate pseudogene accumulation in Mycobacterium leprae? Trends Microbiol. 11(2), 59-61 (2003).
27. Tyagi JS, Saini DK: Did the loss of two-component systems initiate pseudogene accumulation in Mycobacterium leprae? Microbiology 150(Pt 1), 4-7 (2004).
28. Suzuki K, Nakata N, Bang PD, Ishii N, Makino M: High-level expression of pseudogenes in Mycobacterium leprae. FEMS Microbiol. Lett. 259(2), 208-214 (2006).
29. Nakamura K, Akama T, Bang PD et al.: Detection of RNA expression from pseudogenes and non-coding genomic regions of Mycobacterium leprae. Microb. Pathog. 47(3), 183-187 (2009).
30. Williams DL, Slayden RA, Amin A et al.: Implications of high level pseudogene transcription in Mycobacterium leprae. BMC Genomics 10, 397 (2009).
31. Akama T, Suzuki K, Tanigawa K et al.: Whole-genome tiling array analysis of Mycobacterium leprae RNA reveals high expression of pseudogenes and noncoding regions. J. Bacteriol. 191(10), 3321-3327 (2009).
32. Mira A, Pushker R, Rodriguez-Valera F: The Neolithic revolution of bacterial genomes. Trends Microbiol. 14(5), 200-206 (2006).
33. Eddy SR: Non-coding RNA genes and the modern RNA world. Nat. Rev. Genet. 2(12), 919-929 (2001).
34. Erdmann VA, Barciszewska MZ, Hochberg A, de Groot N, Barciszewski J: Regulatory RNAs. Cell Mol. Life Sci. 58(7), 960-977 (2001).
35. Korneev SA, Park JH, O'Shea M: Neuronal expression of neural nitric oxide synthase (nNOS) protein is suppressed by an antisense RNA transcribed from an NOS pseudogene. J. Neurosci. 19(18), 7711-7720 (1999).
36. Lu W, Zhou D, Glusman G et al.: KLK31P is a novel androgen regulated and transcribed pseudogene of kallikreins that is expressed at lower levels in prostate cancer cells than in normal prostate cells. Prostate 66(9), 936-944 (2006).
37. Suo G, Han J, Wang X, Zhang J, Zhao Y, Dai J: Oct4 pseudogenes are transcribed in cancers. Biochem. Biophys. Res. Commun. 337(4), 1047-1051 (2005).
38. Kandouz M, Bier A, Carystinos GD, Alaoui-Jamali MA, Batist G: Connexin43 pseudogene is expressed in tumor cells and inhibits growth. Oncogene 23(27), 4763-4770 (2004).
39. Graur D, Shuali Y, Li WH: Deletions in processed pseudogenes accumulate faster in rodents than in humans. J. Mol. Evol. 28(4), 279-285 (1989).
40. Gomez-Valero L, Latorre A, Silva FJ: The evolutionary fate of nonfunctional DNA in the bacterial endosymbiont Buchnera aphidicola. Mol. Biol. Evol. 21(11), 2172-2181 (2004).
41. Han XY, Seo YH, Sizer KC et al.: A new Mycobacterium species causing diffuse lepromatous leprosy. Am. J. Clin. Pathol. 130(6), 856-864 (2008).
42. Han XY, Sizer KC, Thompson EJ et al.: Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis. J. Bacteriol. 191(19), 6067-6074 (2009).
43. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL: The continuing challenges of leprosy. Clin. Microbiol. Rev. 19(2), 338-381 (2006).
44. Cambau E, Perani E, Guillemin I, Jamet P, Ji B: Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae. Lancet 349(9045), 103-104 (1997).
45. Matsuoka M, Kashiwabara Y, Namisato M: A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin. Int. J. Lepr. Other Mycobact. Dis. 68(4), 452-455 (2000).
46. Cambau E, Bonnafous P, Perani E, Sougakoff W, Ji B, Jarlier V: Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy. Clin. Infect. Dis. 34(1), 39-45 (2002).
47. Matsuoka M, Kashiwabara Y, Liangfen Z, Goto M, Kitajima S: A second case of multidrug-resistant Mycobacterium leprae isolated from a Japanese patient with relapsed lepromatous leprosy. Int. J. Lepr. Other Mycobact. Dis. 71(3), 240-243 (2003).
48. Maeda S, Matsuoka M, Nakata N et al.: Multidrug resistant Mycobacterium leprae from patients with leprosy. Antimicrob. Agents Chemother. 45(12), 3635-3639 (2001).
49. Matsuoka M, Budiawan T, Aye KS et al.: The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines. Lepr. Rev. 78(4), 343-352 (2007).
50. World Health Organization. Guidelines for global surveillance of drug resistance in leprosy. SEA-GLP 1-32 (2009).
51. Shepard CC, Congdon CC: Increased growth of Mycobacterium leprae in thymectomized-irradiated mice after foot pad inoculation. Int. J. Lepr. Other Mycobact. Dis. 36(2), 224-227 (1968).
52. Pettit JHS, Rees RJW: Sulphone resistance in leprosy: an experimental and clinical study. Lancet 284(7361), 673-674 (1964).
53. Franzblau SG: Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system. Antimicrob. Agents Chemother. 33(12), 2115-2117 (1989).
54. Matsuoka M: Drug resistance in leprosy. Jpn. J. Infect. Dis. 63(1), 1-7 (2010).
55. Honore N, Cole ST: Molecular basis of rifampin resistance in Mycobacterium leprae. Antimicrob. Agents Chemother. 37(3), 414-418 (1993).
56. Honore N, Roche PW, Grosset JH, Cole ST: A method for rapid detection of rifampicin-resistant isolates of Mycobacterium leprae. Lepr. Rev. 72(4), 441-448 (2001).
57. Williams DL, Gillis TP: Molecular detection of drug resistance in Mycobacterium leprae. Lepr. Rev. 75(2), 118-130 (2004).
58. Williams DL, Spring L, Harris E, Roche P, Gillis TP: Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance. Antimicrob. Agents Chemother. 44(6), 1530-1537 (2000). (Pubitemid 30340790)
59. Williams DL, Pittman TL, Gillis TP, Matsuoka M, Kashiwabara Y: Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis. J. Clin. Microbiol. 39(6), 2083-2088 (2001).
60. Gillis TP, Williams DL: Dapsone resistance in Mycobacterium leprae. Lepr. Rev. 71(Suppl.), S91-S95 (2000).
61. Lee SB, Kim SK, Kang TJ et al.: The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea. Ann. Trop. Med. Parasitol. 95(4), 429-432 (2001).
62. Cambau E, Carthagena L, Chauffour A, Ji B, Jarlier V: Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy. Clin. Infect. Dis. 42(2), 238-241 (2006).
63. Gillis TP, William DL: Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 of Mycobacterium leprae. Indian J. Lepr. 71, 11-18 (1999).
64. Matsuoka M, Aye KS, Kyaw K et al.: A novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries. J. Med. Microbiol. 57(Pt 10), 1213-1219 (2008).
65. Ling DI, Zwerling AA, Pai M: GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J. 32(5), 1165-1174 (2008).
66. Donoghue HD, Holton J, Spigelman M: PCR primers that can detect low levels of Mycobacterium leprae DNA. J. Med. Microbiol. 50(2), 177-182 (2001).
67. Monot M, Honore N, Garnier T et al.: On the origin of leprosy. Science 308(5724), 1040-1042 (2005).
68. Filliol I, Motiwala AS, Cavatore M et al.: Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J. Bacteriol. 188(2), 759-772 (2006).
69. Hunter PR, Gaston MA: Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J. Clin. Microbiol. 26(11), 2465-2466 (1988).
70. Hunter PR: Reproducibility and indices of discriminatory power of microbial typing methods. J. Clin. Microbiol. 28(9), 1903-1905 (1990).
71. Lovett ST: Encoded errors: mutations and rearrangements mediated by misalignment at repetitive DNA sequences. Mol. Microbiol. 52(5), 1243-1253 (2004).
72. Reyes JF, Tanaka MM: Mutation rates of spoligotypes and variable number tandem repeat loci in Mycobacterium tuberculosis. Infect. Genet. Evol. 10(7), 1046-1051 (2010).
73. Monot M, Honore N, Baliere C et al.: Are variable-number tandem repeats appropriate for genotyping Mycobacterium leprae? J. Clin. Microbiol. 46(7), 2291-2297 (2008).
74. Truman R, Fontes AB, de Miranda AB, Suffys P, Gillis T: Genotypic variation and stability of four variable-number tandem repeats and their suitability for discriminating strains of Mycobacterium leprae. J. Clin. Microbiol. 42(6), 2558-2565 (2004).
75. Young SK, Ponnighaus JM, Jain S et al.: Use of short tandem repeat sequences to study Mycobacterium leprae in leprosy patients in Malawi and India. PLoS Negl. Trop. Dis. 2(4), e214 (2008).
76. Gillis T, Vissa V, Matsuoka M et al.: Characterisation of short tandem repeats for genotyping Mycobacterium leprae. Lepr. Rev. 80(3), 250-260 (2009).
77. Xing Y, Liu J, Sakamuri RM et al.: VNTR typing studies of Mycobacterium leprae in China: assessment of methods and stability of markers during treatment. Lepr. Rev. 80(3), 261-271 (2009).
78. Shinde V, Newton H, Sakamuri RM et al.: VNTR typing of Mycobacterium leprae in South Indian leprosy patients. Lepr. Rev. 80(3), 290-301 (2009).
79. Sakamuri RM, Harrison J, Gelber R et al.: A continuation: study and characterisation of Mycobacterium leprae short tandem repeat genotypes and transmission of leprosy in Cebu, Philippines. Lepr. Rev. 80(3), 272-279 (2009).
80. Hall BG: Molecular epidemiology of Mycobacterium leprae: a solid beginning. Lepr. Rev. 80(3), 246-249 (2009).
81. Hall BG, Salipante SJ: Molecular epidemiology of Mycobacterium leprae as determined by structure-neighbor clustering. J. Clin. Microbiol. 48(6), 1997-2008 (2010).
82. Matsuoka M: Recent advances in the molecular epidemiology of leprosy. Nihon Hansenbyo Gakkai Zasshi 78(1), 67-73 (2009).
83. Cavalli-Sforza LL, Feldman MW: The application of molecular genetic approaches to the study of human evolution. Nat. Genet. 33(Suppl.), 266-275 (2003).
84. Pavesi A: Microbes coevolving with human host and ancient human migrations. J. Anthropol. Sci. 83, 9-28 (2005).
85. Rinaldi A: Tiny travel companions. As microorganisms have accompanied mankind's journeys around the globe, they could help scientists to unravel our past. EMBO Rep. 8(2), 121-125 (2007).
86. Pavesi A: Origin and evolution of GBV-C/ hepatitis G virus and relationships with ancient human migrations. J. Mol. Evol. 53(2), 104-113 (2001).
87. Sugimoto C, Kitamura T, Guo J et al.: Typing of urinary JC virus DNA offers a novel means of tracing human migrations. Proc. Natl Acad. Sci. USA 94(17), 9191-9196 (1997).
88. Pavesi A: Utility of JC polyomavirus in tracing the pattern of human migrations dating to prehistoric times. J. Gen. Virol. 86(Pt 5), 1315-1326 (2005).
89. Fisher MC, Koenig GL, White TJ et al.: Biogeographic range expansion into South America by Coccidioides immitis mirrors New World patterns of human migration. Proc. Natl Acad. Sci. USA 98(8), 4558-4562 (2001).
90. Falush D, Wirth T, Linz B et al.: Traces of human migrations in Helicobacter pylori populations. Science 299(5612), 1582-1585 (2003).
91. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R: Helicobacter pylori virulence and genetic geography. Science 284(5418), 1328-1333 (1999).
92. Linz B, Balloux F, Moodley Y et al.: An African origin for the intimate association between humans and Helicobacter pylori. Nature 445(7130), 915-918 (2007).
93. Rafi A, Spigelman M, Stanford J, Lemma E, Donoghue H, Zias J: Mycobacterium leprae DNA from ancient bone detected by PCR. Lancet 343(8909), 1360-1361 (1994).
94. Montiel R, Garcia C, Canadas MP, Isidro A, Guijo JM, Malgosa A: DNA sequences of Mycobacterium leprae recovered from ancient bones. FEMS Microbiol. Lett. 226(2), 413-414 (2003).
95. Matheson CD, Vernon KK, Lahti A et al.: Molecular exploration of the first-century Tomb of the Shroud in Akeldama, Jerusalem. PLoS ONE 4(12), e8319 (2009).
96. Watson CL, Lockwood DNJ: Single nucleotide polymorphism analysis of European archaeological Mycobacterium leprae DNA. PLoS ONE 4(10), e7547 (2009).
97. Taylor GM, Blau S, Mays S et al.: Mycobacterium leprae genotype amplified from an archaeological case of lepromatous leprosy in Central Asia. J. Archaeol. Sci. 36(10), 2408-2414 (2009).
98. Suzuki K, Takigawa W, Tanigawa K et al.: Detection of Mycobacterium leprae DNA from archaeological skeletal remains in Japan using whole genome amplification and polymerase chain reaction. PLoS ONE 5(8), e12422 (2010).
99. Donoghue HD, Marcsik A, Matheson C et al.: Co-infection of Mycobacterium tuberculosis and Mycobacterium leprae in human archaeological samples: a possible explanation for the historical decline of leprosy. Proc. Biol. Sci. 272(1561), 389-394 (2005).
100. Haas CJ, Zink A, Pálfi G, Szeimies U, Nerlich AG: Detection of leprosy in ancient human skeletal remains by molecular identification of Mycobacterium leprae. Am. J. Clin. Pathol. 114(3), 428-436 (2000).
101. Achtman M, Morelli G, Zhu P et al.: Microevolution and history of the plague bacillus, Yersinia pestis. Proc. Natl Acad. Sci. USA 101(51), 17837-17842 (2004).
102. Gagneux S, Small PM: Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect. Dis. 7(5), 328-337 (2007).
103. Achtman M: Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annu. Rev. Microbiol. 62, 53-70 (2008).
104. Shin Y-C, Lee H, Lee H, Walsh GP, Kim J-D, Cho S-N: Variable numbers of TTC repeats in Mycobacterium leprae DNA from leprosy patients and use in strain differentiation. J. Clin. Microbiol. 38(12), 4535-4538 (2000).
105. Groathouse NA, Rivoire B, Kim H et al.: Multiple polymorphic loci for molecular typing of strains of Mycobacterium leprae. J. Clin. Microbiol. 42(4), 1666-1672 (2004).
106. Young SK, Taylor GM, Jain S et al.: Microsatellite mapping of Mycobacterium leprae populations in infected humans. J. Clin. Microbiol. 42(11), 4931-4936 (2004).
107. Weng X, Wang Z, Liu J et al.: Identification and distribution of Mycobacterium leprae genotypes in a region of high leprosy prevalence in China: a 3-year molecular epidemiological study. J. Clin. Microbiol. 45(6), 1728-1734 (2007).
108. Srisungngam S, Rudeeaneksin J, Wattanpokayakit S et al.: Typing of Thai clinical isolates of Mycobacterium leprae and analysis of leprosy transmission by polymorphism of tandem repeats. Southeast Asian J. Trop. Med. Public Health 38(4), 714-720 (2007).
109. Matsuoka M, Maeda S, Kai M et al.: Mycobacterium leprae typing by genomic diversity and global distribution of genotypes. Int. J. Lepr. Other Mycobact. Dis. 68(2), 121-128 (2000).
110. Matsuoka M, Zhang L, Morris MF, Legua P, Wiens C: Polymorphism in the rpoT gene in Mycobacterium leprae isolates obtained from Latin American countries and its possible correlation with the spread of leprosy. FEMS Microbiol. Lett. 243(2), 311-315 (2005).
111. Lavania M, Katoch K, Singh H et al.: Predominance of three copies of tandem repeats in rpoT gene of Mycobacterium leprae from Northern India. Infect. Genet. Evol. 7(5), 627-631 (2007).
112. Lavania M, Lal R, Joseph G et al.: Genotypic analysis of Mycobacterium leprae strains from different regions of India on the basis of rpoT. Indian J. Lepr. 81(3), 119-124 (2009).
113. Zhang L, Budiawan T, Matsuoka M: Diversity of potential short tandem repeats in Mycobacterium leprae and application for molecular typing. J. Clin. Microbiol. 43(10), 5221-5229 (2005).
114. Kimura M, Sakamuri RM, Groathouse NA et al.: Rapid variable-number tandem-repeat genotyping for Mycobacterium leprae clinical specimens. J. Clin. Microbiol. 47(6), 1757-1766 (2009).
115. Balagon MF, Cellona RV, Cruz E et al.: Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines. Am. J. Trop. Med. Hyg. 81(5), 895-899 (2009).
116. Suzuki K, Udono T, Fujisawa M, Tanigawa K, Idani Gi, Ishii N: Infection during infancy and long incubation period of leprosy suggested in the case of a chimpanzee used for medical research. J. Clin. Microbiol. 48(9), 3432-3434 (2010).